Virtus ETF Advisers LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$315,380
-7.1%
3,368
-11.4%
0.19%
-4.5%
Q2 2023$339,329
+24.8%
3,802
+49.9%
0.20%
+34.0%
Q1 2023$271,910
-10.6%
2,536
+1.8%
0.15%
-5.7%
Q4 2022$304,226
+1.7%
2,491
-14.1%
0.16%
+33.6%
Q3 2022$299,000
+12.8%
2,900
+1.5%
0.12%
+21.4%
Q2 2022$265,000
-16.9%
2,856
+4.9%
0.10%
-31.5%
Q1 2022$319,000
-12.8%
2,7220.0%0.14%
+3.6%
Q4 2021$366,000
+45.2%
2,722
+72.2%
0.14%
+24.3%
Q3 2021$252,000
+15.1%
1,581
-5.0%
0.11%
+23.3%
Q2 2021$219,000
+3.8%
1,664
+1.4%
0.09%
+1.1%
Q1 2021$211,000
-21.6%
1,641
+1.7%
0.09%
-20.5%
Q4 2020$269,000
-21.3%
1,614
-27.1%
0.11%
-37.4%
Q3 2020$342,000
-7.8%
2,215
-11.8%
0.18%
+1.7%
Q2 2020$371,000
+5.7%
2,511
-19.4%
0.18%
+22.2%
Q1 2020$351,000
-29.4%
3,117
-12.7%
0.14%
+77.8%
Q4 2019$497,000
+146.0%
3,569
+70.1%
0.08%
+97.6%
Q3 2019$202,000
-20.8%
2,098
-5.2%
0.04%
-24.1%
Q2 2019$255,000
-49.0%
2,214
-47.9%
0.05%
-94.9%
Q1 2019$500,000
+66.7%
4,250
-11.3%
1.06%
+1986.3%
Q4 2018$300,0004,7890.05%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders